enGene Therapeutics Inc (ENGN) vs Unicycive Therapeutics, Inc. (UNCY)

enGene Therapeutics Inc and Unicycive Therapeutics, Inc. are both Biotechnology companies. enGene Therapeutics Inc and Unicycive Therapeutics, Inc. are of similar size ($134.0M and $128.7M). Across the 9 metrics below, enGene Therapeutics Inc leads on 5 and Unicycive Therapeutics, Inc. on 4.

Valuation

Metric ENGN UNCY Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.59 2.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.76 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (105.41%) (37.15%) (28.84%)
Free cash flow yield (76.09%) (21.97%) (23.03%)

Profitability

Metric ENGN UNCY Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (60.50%) (101.07%) (57.72%)
Return on assets (48.84%) (69.05%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENGN UNCY Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (56.85%) 70.18% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENGN UNCY Biotechnology median
Debt to equity 0.11 0.00 0.00
Current ratio 10.21 3.81 4.73
Net debt to EBITDA 1.42 1.43 0.96

Dividend

Metric ENGN UNCY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENGN UNCY Biotechnology median
Market cap 128.67m 133.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack